These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2427603)

  • 1. Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT-6 determinants.
    Foster CA; Holbrook KA; Farr AG
    J Invest Dermatol; 1986 Mar; 86(3):240-3. PubMed ID: 2427603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogeny of Langerhans cells in human embryonic and fetal skin: cell densities and phenotypic expression relative to epidermal growth.
    Foster CA; Holbrook KA
    Am J Anat; 1989 Feb; 184(2):157-64. PubMed ID: 2712007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional development of Langerhans cells and formation of Birbeck granules in human embryonic and fetal skin.
    Fujita M; Furukawa F; Horiguchi Y; Ueda M; Kashihara-Sawami M; Imamura S
    J Invest Dermatol; 1991 Jul; 97(1):65-72. PubMed ID: 1711549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
    Liu HH; Schroeter AL; Muller SA
    Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermal Langerhans cell involvement in cutaneous lupus erythematosus.
    Sontheimer RD; Bergstresser PR
    J Invest Dermatol; 1982 Oct; 79(4):237-43. PubMed ID: 6215451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential distribution of Langerhans cells in organ culture of human skin.
    Elmets CA; Bergstresser PR; Streilein JW
    J Invest Dermatol; 1982 Nov; 79(5):340-5. PubMed ID: 6215452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of Ia-positive and Thy-1-positive leukocytes of murine epidermis.
    Romani N; Schuler G; Fritsch P
    J Invest Dermatol; 1986 Feb; 86(2):129-33. PubMed ID: 2875114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Langerhans cells: methods of identification].
    Nicolas C; Schmitt D
    Pathol Biol (Paris); 1984 Mar; 32(3):199-208. PubMed ID: 6232489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of UVA and UVB irradiation on human epidermal Langerhans cell membrane markers defined by ATPase activity and monoclonal antibodies (OKT 6 and anti-Ia).
    Koulu L; Jansén CT; Viander M
    Photodermatol; 1985 Dec; 2(6):339-46. PubMed ID: 2937025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells.
    Czernielewski JM; Schmitt D; Faure MR; Thivolet J
    Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and three-dimensional analysis of human Langerhans cells in epidermal sheets and vertical skin sections.
    Emilson A; Scheynius A
    J Histochem Cytochem; 1995 Oct; 43(10):993-8. PubMed ID: 7560889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Langerhans cells in epidermal cell culture, in vitro skin explants and skin grafts onto "nude" mice.
    Czernielewski J; Demarchez M; Prunieras M
    Arch Dermatol Res; 1984; 276(5):288-92. PubMed ID: 6593008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells.
    Berman B; Duncan MR; Smith B; Ziboh VA; Palladino M
    J Invest Dermatol; 1985 Jan; 84(1):54-8. PubMed ID: 2578172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of distinct subpopulations of Langerhans cells by flow cytometry and sorting.
    Vaigot P; Czernielewski J; Prunieras M
    Cytometry; 1985 Sep; 6(5):422-7. PubMed ID: 2931262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny and characterization of factor XIIIa+ cells in developing human skin.
    Gibran NS; Nickoloff BJ; Holbrook KA
    Anat Embryol (Berl); 1996 Jan; 193(1):35-41. PubMed ID: 8838494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
    de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
    J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The appearance, density and distribution of melanocytes in human embryonic and fetal skin revealed by the anti-melanoma monoclonal antibody, HMB-45.
    Holbrook KA; Underwood RA; Vogel AM; Gown AM; Kimball H
    Anat Embryol (Berl); 1989; 180(5):443-55. PubMed ID: 2619087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
    Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
    Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.